Oceania (ASX:OCA) share price rises on new CEO announcement

The Oceania Healthcare Ltd (ASX: OCA) share price has risen slightly today after the New Zealand healthcare provider appointed a new CEO.

| More on:
healthcare worker overseeing group of aged care residents at table

Image Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Oceania Healthcare Ltd (ASX: OCA) share price has risen slightly today after the New Zealand healthcare provider appointed former CFO, Brent Sutton, as its new CEO effective immediately.

Sutton only joined Oceania in January 2020 but previously worked with the company during its IPO in 2017. Sutton is a former investment banker and qualified chartered accountant and has led mergers, acquisitions, takeovers and capital market transactions.

Oceania Chair, Liz Coutts, said that Sutton has already had a major impact on the company.

"Brent has made a significant contribution to both the strategic direction and the performance of Oceania Healthcare over the last 15 months in his role as Chief Financial Officer. He has the full trust of the board and the executive leadership team, and has built a strong relationship with the investment community," she said. 

Oceania share price grows after COVID downturn, CEO poaching

Sutton's appointment came after former Oceania CEO Earl Gasparich was poached by rival retirement village provider Metlifecare Limited this month.

Sutton said he was aiming to transform New Zealand's retirement sector,  Oceania caters for approximately 3,500 residents across the country.

"I have been privileged to be part of the success of the company and am very excited to have the opportunity to lead our highly skilled team into the next stage of growth.

"I am passionate about transforming the retirement and aged care experience in New Zealand, putting our residents at the heart of all that we do."

The Oceania share price has been a reasonably steady grower over the past five years excluding a swift downturn at the height of the COVID-19 pandemic in March 2020.

In the past 12 months, Oceania shares have risen from a low of 51 cents to $1.41 today.

The Oceania share price was up 0.71% after the announcement and has risen more than 90% year-to-date. The company is listed on the ASX and New Zealand's NZX, with a market capitalisation of AU$853 million. 

Motley Fool contributor Lucas Radbourne-Pugh has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Male doctor in a lab coat working at laptop looking serious.
Healthcare Shares

This bombshell for ASX healthcare shares could hit 6 million Australians

This could have a large impact.

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

2 ASX healthcare shares having a stellar run today

The ASX healthcare sector is down today but these two stocks are bucking the trend.

Read more »

A company manager presents the ASX company earnings report to shareholders at an AGM.
Healthcare Shares

Why this $13 billion ASX 200 healthcare stock is surging today

A change in sentiment for the healthcare player.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

This ASX 200 stock hit a 52-week low and a top broker thinks it can rebound

Patient investors may see this stock make a pleasing recovery.

Read more »

A couple smile as they look at a pregnancy test.
Healthcare Shares

Why this sold-off ASX healthcare share could be an exciting dividend buy

This could be a healthy stock for dividends.

Read more »

a smiling woman sits at her computer at home with a coffee alongside her, as if pleased with her investments.
Healthcare Shares

Is CSL the best ASX 100 share to buy now?

Bell Potter has good things to say about this blue chip star.

Read more »

Scientists in a laboratory look at a computer screen with anticipation on their faces representing a potential change in the performance of ASX biotech shares in FY23
Healthcare Shares

Down 10% in a month, are CSL shares feeling the sting of a potential disruption?

Brokers are still bullish.

Read more »

One girl leapfrogs over her friend's back.
Healthcare Shares

Doubled in a year! Does this booming ASX share have another 24% upside?

Let's take a look.

Read more »